litlas
Log inCreate account

Philip L. McCarthy

Active 1971–2025

108
Papers
19,730
Citations
78
h-index
105
i10-index

Citations

Citations per year for Philip L. McCarthy1976: 1 citations1977: 1 citations1979: 1 citations1980: 1 citations1981: 1 citations1982: 2 citations1986: 4 citations1988: 4 citations1991: 4 citations1992: 5 citations1993: 11 citations1994: 11 citations1995: 3 citations1996: 5 citations1997: 13 citations1998: 23 citations1999: 28 citations2000: 31 citations2001: 19 citations2002: 19 citations2003: 38 citations2004: 19 citations2005: 27 citations2006: 56 citations2007: 74 citations2008: 75 citations2009: 72 citations2010: 109 citations2011: 94 citations2012: 85 citations2013: 106 citations2014: 94 citations2015: 124 citations2016: 102 citations2017: 106 citations2018: 112 citations2019: 548 citations2020: 668 citations2021: 615 citations2022: 439 citations2023: 409 citations2024: 752 citations2025: 316 citations2026: 17 citations1978: no citations, so this year is not shown1983–1985: no citations, so these years are not shown1987: no citations, so this year is not shown1989–1990: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,275 citing papers, 26% of this breakdownGermany: 573 citing papers, 6.5% of this breakdownUnited Kingdom: 526 citing papers, 6% of this breakdownItaly: 489 citing papers, 5.6% of this breakdownFrance: 483 citing papers, 5.5% of this breakdownChina: 470 citing papers, 5.4% of this breakdownSpain: 421 citing papers, 4.8% of this breakdownCanada: 323 citing papers, 3.7% of this breakdownNetherlands: 312 citing papers, 3.6% of this breakdownAustralia: 238 citing papers, 2.7% of this breakdownJapan: 205 citing papers, 2.3% of this breakdownBelgium: 186 citing papers, 2.1% of this breakdown
0%26%Other 25.8%

Institutions

Fields

  • Medicine89%
  • Biochemistry, Genetics and Molecular Biology5.5%
  • Immunology and Microbiology3.4%
  • Neuroscience0.4%
  • Environmental Science0.3%
  • Engineering0.2%
  • Other1.2%

Topics

  • Multiple Myeloma Research and Treatments12.1%
  • Hematopoietic Stem Cell Transplantation8.9%
  • Protein Degradation and Inhibitors5.6%
  • Acute Myeloid Leukemia Research4.8%
  • CAR-T cell therapy research4.6%
  • Acute Lymphoblastic Leukemia research3%
  • Other61%

Coauthors

All papers

Open in search
  1. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

    Authors: Shaji Kumar, Bruno Paiva, Kenneth C. Anderson, Brian G.M. Durie, Ola Landgren, Philippe Moreau, Nikhil C. Munshi, Sagar Lonial, Joan Bladé, María‐Victoria Mateos, Meletios Α. Dimopoulos, Efstathios Kastritis, Mario Boccadoro, Robert Z. Orlowski, Hartmut Goldschmidt, Andrew Spencer, Jian Hou, Wee Joo Chng, Saad Z. Usmani, Elena Zamagni, Kazuyuki Shimizu, Sundar Jagannath, Hans Erik Johnsen, Evangelos Terpos, Tony Reiman, Robert A. Kyle, Pieter Sonneveld, Paul G. Richardson, Philip L. McCarthy, Heinz Ludwig, Wen-Ming Chen, Michèle Cavo, Jean‐Luc Harousseau, Suzanne Lentzsch, Jens Hillengaß, Antonio Palumbo, Alberto Órfão, S. Vincent Rajkumar, Jesús F. San Miguel, Hervé Avet‐Loiseau - The Lancet Oncology 2016 cited by 2,995

  2. β2 adrenergic receptor–mediated signaling regulates the immunosuppressive potential of myeloid-derived suppressor cells

    Authors: Hemn Mohammadpour, Cameron R. MacDonald, Guanxi Qiao, Minhui Chen, Bowen Dong, Bonnie L. Hylander, Philip L. McCarthy, Scott I. Abrams, Elizabeth A. Repasky - Journal of Clinical Investigation 2019 cited by 294

  3. Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma

    Authors: Paul G. Richardson, Susanna Jacobus, Edie Weller, Hani Hassoun, Sagar Lonial, Noopur Raje, Eva Medvedova, Philip L. McCarthy, Edward N. Libby, Peter M. Voorhees, Robert Z. Orlowski, Larry D. Anderson, Jeffrey A. Zonder, Carter P. Milner, Cristina Gasparetto, Mounzer Agha, Abdullah Khan, David D. Hurd, Krisstina Gowin, Rammurti T. Kamble, Sundar Jagannath, Nitya Nathwani, Melissa Alsina, Robert F. Cornell, Hamza Hashmi, Erica Campagnaro, Astrid C. Andreescu, Teresa Gentile, Michaela Liedtke, Kelly Godby, Adam D. Cohen, Thomas H. Openshaw, Marcelo C. Pasquini, Sergio Giralt, Jonathan L. Kaufman, Andrew J. Yee, Emma C. Scott, Pallawi Torka, Amy Foley, Mariateresa Fulciniti, Kyle Hebert, Mehmet Samur, Kelly Masone, Michelle E. Maglio, Andrea A. Zeytoonjian, Omar Nadeem, Robert Schlossman, Jacob P. Laubach, Claudia E. Paba‐Prada, Irene M. Ghobrial, Aurore Perrot, Philippe Moreau, Hervé Avet‐Loiseau, Michel Attal, Kenneth C. Anderson, Nikhil C. Munshi - New England Journal of Medicine 2022 cited by 463

  4. Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial

    Authors: David S. Hong, Brian A. Van Tine, Swethajit Biswas, Cheryl McAlpine, Melissa L. Johnson, Anthony J. Olszanski, Jeffrey Clarke, Dejka M. Araujo, George R. Blumenschein, Partow Kebriaei, Quan Lin, Alex J. Tipping, Joseph P. Sanderson, Ruoxi Wang, Trupti Trivedi, Thejo Annareddy, Jane P. F. Bai, Stavros Rafail, Amy Sun, Lilliam Fernandes, Jean‐Marc Navenot, Frederic D. Bushman, J.K. Everett, Derin F. Karadeniz, Robyn Broad, Martin Isabelle, Revashnee Naidoo, Natalie Bath, Gareth Betts, Zohar Wolchinsky, Dzmitry G. Batrakou, Erin Van Winkle, Erica Elefant, Armin Ghobadi, Amanda F. Cashen, Anne Grand’Maison, Philip L. McCarthy, Paula M. Fracasso, Elliot Norry, Dennis Williams, Mihaela Druta, David A. Liebner, Kunle Odunsi, Marcus O. Butler - Nature Medicine 2023 cited by 194

  5. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events

    Authors: Marcela V. Maus, S. Alexander, Michael R. Bishop, Jennifer N. Brudno, Colleen Callahan, Marco L. Davila, Claudia Diamonte, Jörg Dietrich, Julie C. Fitzgerald, Matthew J. Frigault, Terry J. Fry, Jennifer Holter‐Chakrabarty, Krishna V. Komanduri, Daniel W Lee, Frederick L. Locke, Shannon L. Maude, Philip L. McCarthy, Elena Mead, Sattva S. Neelapu, Tomas G. Neilan, Bianca Santomasso, Elizabeth J. Shpall, David T. Teachey, Cameron J. Turtle, Tom Whitehead, Stephan A. Grupp - Journal for ImmunoTherapy of Cancer 2020 cited by 269

  6. β2-adrenergic receptor signaling regulates metabolic pathways critical to myeloid-derived suppressor cell function within the TME

    Authors: Hemn Mohammadpour, Cameron R. MacDonald, Philip L. McCarthy, Scott I. Abrams, Elizabeth A. Repasky - Cell Reports 2021 cited by 135

  7. Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report

    Authors: Antonio Palumbo, Sara Bringhen, María‐Victoria Mateos, Alessandra Larocca, Thierry Façon, Shaji Kumar, Massimo Offidani, Philip L. McCarthy, Andrea Evangelista, Sagar Lonial, Sonja Zweegman, Pellegrino Musto, Evangelos Terpos, Andrew Belch, Roman Hájek, Heinz Ludwig, A. Keith Stewart, Philippe Moreau, Kenneth C. Anderson, Hermann Einsele, Brian G.M. Durie, Meletios Α. Dimopoulos, Ola Landgren, Jesús F. San Miguel, Paul G. Richardson, Pieter Sonneveld, S. Vincent Rajkumar - Blood 2015 cited by 762

  8. Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis

    Authors: Philip L. McCarthy, Sarah A. Holstein, Maria Teresa Petrucci, Paul G. Richardson, Cyrille Hulin, Patrizia Tosi, Sara Bringhen, Pellegrino Musto, Kenneth C. Anderson, D. Caillot, Francesca Gay, Philippe Moreau, Gérald Marit, Sin‐Ho Jung, Zhinuan Yu, Benjamin Winograd, Robert Knight, Antonio Palumbo, Michel Attal - Journal of Clinical Oncology 2017 cited by 679

  9. Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research

    Authors: Sally Arai, Mukta Arora, Tao Wang, Stephen R. Spellman, Wensheng He, Daniel R. Couriel, Álvaro Urbano-Ispizúa, Corey Cutler, Andrea A. Bacigalupo, Minoo Battiwalla, Mary E.D. Flowers, Mark Juckett, Stephanie J. Lee, Alison W. Loren, Thomas R. Klumpp, Susan E. Prockup, Olle Ringdén, Bipin N. Savani, Gèrard Socié, Kirk R. Schultz, Thomas R. Spitzer, Takanori Teshima, Christopher Bredeson, David A. Jacobsohn, Robert J. Hayashi, William R. Drobyski, Haydar Frangoul, Görgün Akpek, Vincent T. Ho, Victor Lewis, Robert Peter Gale, John Koreth, Nelson J. Chao, Mahmoud Aljurf, Brenda Cooper, Mary J. Laughlin, Jack W. Hsu, Peiman Hematti, Leo F. Verdonck, Melhelm M. Solh, Maxim Norkin, Vijay Reddy, Rodrigo Martino, Shahinaz M. Gadalla, Jenna D. Goldberg, Philip L. McCarthy, Josè Antonio Pérez-Simón, Nandita Khera, Ian D. Lewis, Yoshiko Atsuta, Richard F. Olsson, Wael Saber, Edmund K. Waller, Didier Blaise, Joseph A. Pidala, Paul J. Martin, Prakash Satwani, Martin Bornhäuser, Yoshihiro Inamoto, Daniel J. Weisdorf, Mary M. Horowitz, Steven Z. Pavletic - Biology of Blood and Marrow Transplantation 2014 cited by 435

  10. Immunomodulatory Drugs in Multiple Myeloma: Mechanisms of Action and Clinical Experience

    Authors: Sarah A. Holstein, Philip L. McCarthy - Drugs 2017 cited by 258

  11. Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma

    Authors: Philip L. McCarthy, Kouros Owzar, Craig C. Hofmeister, David D. Hurd, Hani Hassoun, Paul G. Richardson, Sergio Giralt, Edward A. Stadtmauer, Daniel J. Weisdorf, Ravi Vij, Jan S. Moreb, Natalie S. Callander, Koen van Besien, Teresa Gentile, Luis Isola, Richard T. Maziarz, Don A. Gabriel, Asad Bashey, Heather Landau, Thomas Martin, Muzaffar H. Qazilbash, Denise Levitan, Brian McClune, Robert Schlossman, Vera Hárs, John Postiglione, Chen Jiang, Elizabeth Bennett, Susan Barry, Linda R. Bressler, Michael E. Kelly, Michele Seiler, Cara A. Rosenbaum, Parameswaran Hari, Marcelo C. Pasquini, Mary M. Horowitz, Thomas C. Shea, Steven M. Devine, Kenneth C. Anderson, Charles Linker - New England Journal of Medicine 2012 cited by 1,143

  12. Risk factors for acute GVHD and survival after hematopoietic cell transplantation

    Authors: Madan Jagasia, Mukta Arora, Mary E.D. Flowers, Nelson J. Chao, Philip L. McCarthy, Corey Cutler, Álvaro Urbano-Ispizúa, Steven Z. Pavletic, Michael Haagenson, Mei-Jie Zhang, Joseph H. Antin, Brian J. Bolwell, Christopher Bredeson, Jean‐Yves Cahn, Mitchell S. Cairo, Robert Peter Gale, Vikas Gupta, Stephanie J. Lee, Mark R. Litzow, Daniel J. Weisdorf, Mary M. Horowitz, Theresa Hahn - Blood 2011 cited by 697

  13. Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States

    Authors: Lori Muffly, Marcelo C. Pasquini, Michael J. Martens, Ruta Brazauskas, Xiaochun Zhu, Kehinde Adekola, Mahmoud Aljurf, Karen K. Ballen, Ashish Bajel, Frédéric Baron, Minoo Battiwalla, Amer Beitinjaneh, Jean‐Yves Cahn, Mathew Carabasi, Yi‐Bin Chen, Saurabh Chhabra, Stefan O. Ciurea, Edward A. Copelan, Anita D’Souza, John Edwards, James M. Foran, César O. Freytes, Henry C. Fung, Robert Peter Gale, Sergio Giralt, Shahrukh K. Hashmi, Gerhard Hildebrandt, Vincent T. Ho, Ann A. Jakubowski, Hillard M. Lazarus, Marlise R. Luskin, Rodrigo Martino, Richard T. Maziarz, Philip L. McCarthy, Taiga Nishihori, Rebecca L. Olin, Richard F. Olsson, Attaphol Pawarode, Edward Peres, Andrew R. Rezvani, David A. Rizzieri, Bipin N. Savani, Harry C. Schouten, Mitchell Sabloff, Matthew D. Seftel, Sachiko Seo, Mohamed L. Sorror, Jeff Szer, Baldeep Wirk, William A. Wood, Andrew Artz - Blood 2017 cited by 296

  14. Cytomegalovirus reactivation after CD19 CAR T-cell therapy is clinically significant

    Authors: George Chen, Megan M. Herr, Jan Nowak, Christine M. Ho, Nikolaos G. Almyroudis, Kristopher Attwood, John P. Bonnewell, Marissa Walsh, Brahm H. Segal, Maureen Ross, Philip L. McCarthy, Theresa Hahn - Haematologica 2022 cited by 44

  15. Myeloid-derived suppressor cell mitochondrial fitness governs chemotherapeutic efficacy in hematologic malignancies

    Authors: Saeed Daneshmandi, Jee Eun Choi, Yan Qi, Cameron R. MacDonald, Manu Pandey, Mounika Goruganthu, Nathan Roberts, Prashant Kumar Singh, Richard M. Higashi, Andrew N. Lane, Teresa W.‐M. Fan, Jianmin Wang, Philip L. McCarthy, Elizabeth A. Repasky, Hemn Mohammadpour - Nature Communications 2024 cited by 36

  16. Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial

    Authors: Edward A. Stadtmauer, Marcelo C. Pasquini, Beth Blackwell, Parameswaran Hari, Asad Bashey, Steven M. Devine, Yvonne A. Efebera, S. Ganguly, Cristina Gasparetto, Nancy L. Geller, Mary M. Horowitz, John Koreth, Kristin Knust, Heather Landau, Claudio G. Brunstein, Philip L. McCarthy, Courtney Nelson, Muzaffar H. Qazilbash, Nina Shah, David H. Vesole, Ravi Vij, Dan T. Vogl, Sergio Giralt, George Somlo, Amrita Krishnan - Journal of Clinical Oncology 2019 cited by 259

  17. Deciphering spatial genomic heterogeneity at a single cell resolution in multiple myeloma

    Authors: Maximilian Merz, Almuth Maria Anni Merz, Jie Wang, Lei Wei, Qiang Hu, Nicholas Hutson, Cherie Rondeau, Kimberly Celotto, Ahmed Belal, Ronald Alberico, AnneMarie W. Block, Hemn Mohammadpour, Paul K. Wallace, Joseph D. Tario, Jesse Luce, Sean T. Glenn, Prashant K. Singh, Megan M. Herr, Theresa Hahn, Mehmet Samur, Nikhil C. Munshi, Song Liu, Philip L. McCarthy, Jens Hillengaß - Nature Communications 2022 cited by 68

  18. Results from the First Phase 1 Clinical Study of the B-Cell Maturation Antigen (BCMA) Nex T Chimeric Antigen Receptor (CAR) T Cell Therapy CC-98633/BMS-986354 in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM)

    Authors: Luciano J. Costa, Shaji Kumar, Shebli Atrash, Michaela Liedtke, Gurbakhash Kaur, Benjamin A. Derman, P. Leif Bergsagel, Sham Mailankody, Philip L. McCarthy, Josiana Limones, Yanping Chen, Sharmila Das, Jerill Thorpe, Jonathan J. Cacciatore, Garnet Navarro, Ashley K. Koegel, Michael R. Burgess, Kristen Hege, Shambavi Richard - Blood 2022 cited by 39

  19. Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research Study

    Authors: Mohamed L. Sorror, Brent R. Logan, Xiaochun Zhu, J. Douglas Rizzo, Kenneth R. Cooke, Philip L. McCarthy, Vincent T. Ho, Mary M. Horowitz, Marcelo C. Pasquini - Biology of Blood and Marrow Transplantation 2015 cited by 213

  20. Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: BMT CTN 1401

    Authors: David J. Chung, Nina Shah, Juan Wu, Brent R. Logan, Lina Bisharat, Natalie S. Callander, Giulia Cheloni, Kenneth C. Anderson, Thinle Chodon, Binod Dhakal, Steve Devine, Poorvi Somaiya Dutt, Yvonne A. Efebera, Nancy L. Geller, Haider Ghiasuddin, Peiman Hematti, Leona Holmberg, Alan Howard, Bryon D. Johnson, Dimitra Karagkouni, Hillard M. Lazarus, Ehsan Malek, Philip L. McCarthy, David H. McKenna, Adam Mendizabal, Ajay K. Nooka, Nikhil C. Munshi, Lynn O’Donnell, Aaron P. Rapoport, Jane Reese, Jacalyn Rosenblatt, Robert J. Soiffer, Dina Stroopinsky, Lynne Uhl, Ioannis S. Vlachos, Edmund K. Waller, James W. Young, Marcelo C. Pasquini, David Avigan - Clinical Cancer Research 2023 cited by 29

  21. Second primary malignancies in multiple myeloma: an overview and IMWG consensus

    Authors: Pellegrino Musto, Kenneth C. Anderson, Michel Attal, Paul G. Richardson, A. Badros, Jian Hou, Raymond L. Comenzo, Juan Du, Brian G.M. Durie, Jesús F. San Miguel, Hermann Einsele, W.M. Chen, Laurent Garderet, Giuseppe Pietrantuono, Jens Hillengaß, Robert A. Kyle, Philippe Moreau, Juan José Lahuerta, Ola Landgren, Heinz Ludwig, Alessandra Larocca, Anuj Mahindra, Michèle Cavo, A Mazumder, Philip L. McCarthy, Amara Nouel, S. Vincent Rajkumar, Tony Reiman, Eloísa Riva, Orhan Sezer, Evangelos Terpos, Ingemar Turesson, Saad Z. Usmani, Brendan M. Weiss, Antonio Palumbo - Annals of Oncology 2016 cited by 151

  22. Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT

    Authors: Corey Cutler, Brent R. Logan, Ryotaro Nakamura, Laura Johnston, Sung Won Choi, David Porter, William J. Hogan, Marcelo C. Pasquini, Margaret L. MacMillan, Jack W. Hsu, Edmund K. Waller, Stephan A. Grupp, Philip L. McCarthy, Juan Wu, Zhen‐Huan Hu, Shelly L. Carter, Mary M. Horowitz, Joseph H. Antin - Blood 2014 cited by 217

  23. Developments in continuous therapy and maintenance treatment approaches for patients with newly diagnosed multiple myeloma

    Authors: Meletios Α. Dimopoulos, Andrzej Jakubowiak, Philip L. McCarthy, Robert Z. Orlowski, Michel Attal, Joan Bladé, Hartmut Goldschmidt, Katja Weisel, Karthik Ramasamy, Sonja Zweegman, Andrew Spencer, Jeffrey Huang, Jin Lu, Kazutaka Sunami, Shinsuke Iida, Wee Joo Chng, Sarah A. Holstein, Alberto Rocci, Tomáš Skácel, Richard Labotka, Antonio Palumbo, Kenneth C. Anderson - Blood Cancer Journal 2020 cited by 117

  24. Mass-Fix better predicts for PFS and OS than standard methods among multiple myeloma patients participating on the STAMINA trial (BMT CTN 0702 /07LT)

    Authors: Angela Dispenzieri, Amrita Krishnan, Bonnie K. Arendt, Beth Blackwell, Paul K. Wallace, Surendra Dasari, Dan T. Vogl, Yvonne A. Efebera, Mingwei Fei, Nancy L. Geller, Sergio Giralt, Theresa Hahn, Alan Howard, Mindy Kohlhagen, Heather Landau, Parameswaran Hari, Marcelo C. Pasquini, Muzaffar H. Qazilbash, Philip L. McCarthy, Nina Shah, David H. Vesole, Edward A. Stadtmauer, David Murray - Blood Cancer Journal 2022 cited by 40